Status: Not yet recruiting
Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease
Our study hypothesizes that fluorescein exposure in diabetic patients with advanced chronic kidney disease results in deterioration of kidney function. It will therefore aim to evaluate the incidence of acute kidney injury induced by fluorescein in diabetic patients with CKD. The objective is to determine the incidence, severity and risk factors associated with this deterioration to improve the care of this specific population.
Participants needed: 35
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Saint-Joseph UniversityUpdated: Jan 7, 2025Locations: 1
Eligibility criteria
>18 years old with type 2 or type 1 diabetes and chronic kidney disease stage 3b...
Patients who do not give their consent [+4]